The report describes transparency and registration of clinical research data and maps and develops ‘best practices’ for public, prospective registration and public reporting of clinical trials of all interventions. The report also describes ‘best practices’ for public upload of depersonalised individual participant data after the publication of reports of a clinical trial.

The recommendations from the NTA working group represent attempts to balance the interests of the public; the patients; the trial participants; the trial investigators; the regulatory authorities; and the pharmaceutical, medical devices, and biotechnology industries.

By making the Nordic region a leading force in transparency and trial registration, we will consolidate and expand the trustworthiness of clinical research conducted in the Nordic countries. Hereby, Nordic collaboration and competitiveness in clinical trials can be increased in a global context.

For more information visit or download the report.